Move beyond protection and learn how to turn IP into commercial value. This practical Commercialisation of IP program examines the legal and commercial strategies that support licensing, strategic partnerships, technology transfer, valuation, investment readiness and AI-era content monetisation. Join leading voices across university commercialisation, IP transactions, valuation and copyright licensing to explore how IP, AI, data and content rights can be structured, valued, licensed and monetised in a rapidly changing market. This wording aligns with Legalwise’s internal research that the program should focus on turning IP, technology and innovation into market-ready value, licensing income, investment opportunities and defensible competitive advantage.

Presenters

Tim Heberden, Managing Principal – Valuations, QANTM Valuations; IAM Strategy 300 – The World's Leading IP Strategists (2013–Present)
Tim Heberden is a globally recognised expert in the valuation of intellectual property and intangible assets, with more than 25 years’ experience advising clients across mergers and acquisitions, litigation, tax compliance, strategic planning and intellectual property commercialisation. As Managing Principal – Valuations at QANTM Valuations, Tim helps organisations understand, manage and maximise the value of brands, technology, data and other intangible assets through sophisticated valuation and strategic advisory services. Before joining QANTM Valuations, Tim was a Partner in Deloitte’s M&A Valuation and IP Advisory practices and has advised blue-chip corporates, government agencies, investors and law firms throughout Australia, Asia, Europe and the United Kingdom. His expertise spans intellectual property valuation, royalty determination, technology valuation, brand valuation and value-based management of intangible assets. Tim is a recognised thought leader in the field. He authored the RICS Guidance Note on the Valuation of Intellectual Property Rights and has been named in the prestigious IAM Strategy 300 – The World’s Leading IP Strategists every year since 2013. He has also appeared as an expert witness before Australian courts, the Singapore International Arbitration Centre and the Hong Kong Inland Revenue Board of Review.


Katrina Chambers, Partner, Thomsons
Katrina Chambers is a Partner in Thomsons Intellectual Property and Information Technology team. Her practice includes licensing and commercialisation of IP, assistance with IP ownership and structuring issues, research and development collaborations, alliances and joint venture arrangements, the sale and purchase of IP assets and companies, IP audits and due diligence, regulatory compliance, franchise law, privacy law, manufacturing, supply and distribution agreements, general contracts law and commercial and corporate law. Her clients come from a wide range of private and public industry sectors including life sciences, medical devices, health, information technology, government, university and energy and resources. Katrina has been rated by Doyle's Guide as a Leading IP Lawyer in Queensland and is also recognised by Best Lawyers in the categories of Intellectual Property Law, Biotechnology Law, Commercial Law, Professional Responsibility Practice and Franchise Law.

Josephine Johnston, CEO, Copyright Agency
Josephine Johnston is CEO of Copyright Agency, an Australian not-for-profit organisation that collects licence fees for the reuse of text and images and distributes these as copyright royalty payments to its 40,000 creator members. The fees collected by Copyright Agency support future investment in Australian art, stories and teaching resources. The licences administered by the Copyright Agency enables users to embrace the potential of new technologies in an equitable and ethical way, ensuring that creators are fairly compensated. Jo is a strong advocate for the Australian creative industry and the importance of fair remuneration for the use of their work. She loves this role as it also involves her passion for supporting literacy and the power of reading to transform lives. A lawyer by trade with a background spanning private practice, in-house and Government, Jo has extensive experience in the corporate sector, broadcast media and intellectual property.

Dr Dean Moss, CEO, UniQuest
Dean is CEO of UniQuest, Australia’s leading university commercialisation entity, managing the intellectual property of The University of Queensland. Dean has more than 35 years’ experience in science, academia, business, management and commercialisation in Australia, the US and the UK. He has been managing director or senior business development executive of several health and biotech companies worldwide, including Agen Biomedical, Launch Diagnostics, AMRAD ICT, AMRAD Biotech, and United Drug. Dean established the highly-successful York Medical Technologies as a start-up in the UK in 2004. He is a board member of several Australian biotechnology companies and was a member of the investment committee of the pre-seed venture funds Uniseed, the Medical Research Commercialisation Fund and the New Zealand Government’s KiwiNet. Throughout his career, Dean has managed the raising of more than $200M in venture capital investment. He is Chair of the Group of Eight Universities Innovation and Commercialisation Group. In 2018, Dr Moss was awarded the title of Adjunct Professor in the Office of the UQ’s Deputy Vice-Chancellor (Research & Innovation).

Daniel Splatt, Partner, R&D & (Government Incentives), BDO; Registered Tax Agent (Research & Development)
Daniel Splatt is a Partner in BDO’s Research & Development (R&D) and Government Incentives team in Brisbane, specialising in helping businesses access and maximise government funding opportunities, R&D tax incentives and innovation support programs. With extensive experience advising organisations across the food and agriculture, biotechnology and pharmaceutical sectors, Daniel is recognised for his ability to combine technical expertise with commercial and taxation insights. Daniel advises clients on all aspects of R&D tax incentive compliance and consulting, competitive state and federal grant programs, overseas findings, patent box opportunities and innovation funding strategies. He has successfully managed numerous Australian Taxation Office and AusIndustry reviews and audits, secured successful grant applications under a variety of government programs and assisted businesses to model and optimise the financial benefits of R&D investment. Holding a Bachelor of Science (Biomedical/Neuroscience), a Master of Commerce (Applied Finance) and accreditation as a Registered Tax Agent (Research & Development), Daniel brings a unique combination of scientific, financial and regulatory expertise to his work. He is also an Affiliate Member of Chartered Accountants Australia and New Zealand and an Associate Member of The Tax Institute